Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Heidi Shors

Hand Surgery Kalispell, MT Medical Doctor

NPI 1982899795 CMS profile 1160297

350 Heritage Way Ste 1200, Kalispell, MT 59901

Open in the dashboard

General payments

$108,395

143 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Heidi Shors of Kalispell, MT is reported in the CMS Open Payments database as having received $108,395 across 143 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,972 14
2024 General $10,097 16
2023 General $27,018 15
2022 General $18,306 34
2021 General $10,035 16
2020 General $12,942 21
2019 General $17,025 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heidi Shors
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Heidi Shors were reported at $12,972. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Heidi Shors Hand Surgery median Middle half National median
2019 $17,025 $383 $106–$1,905 $163
2020 $12,942 $172 $51–$1,268 $114
2021 $10,035 $263 $71–$1,591 $132
2022 $18,306 $336 $87–$1,938 $149
2023 $27,018 $233 $81–$1,114 $160
2024 $10,097 $258 $88–$1,203 $164
2025 $12,972 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Endo Pharmaceuticals Inc. $87,771 112 payments
  2. Endo USA, Inc. $20,458 28 payments
  3. IlluminOss Medical, Inc. $114 1 payment
  4. Stryker Corporation $40 1 payment
  5. Pacira Pharmaceuticals Incorporated $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $51,355 10 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $39,975 18 payments
  3. Travel and Lodging $14,432 51 payments
  4. Food and Beverage $2,565 63 payments
  5. Education $68 1 payment
Products named General payments · program years 2019–2025
  1. XIAFLEX $108,229 140 payments
  2. Photodynamic Bone Stabilization Procedure Pack $114 1 payment
  3. VARIAX Non-Locking Plate $40 1 payment
  4. VARIAX Non-Locking Plate $40 1 payment
  5. VARIAX Non-Locking Plate $40 1 payment
  6. Exparel $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$285,702

Of which drugs: $182,597

Medicare patients

342

Average age 73

Services billed

4,518

190 women, 152 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 63%
High blood pressure 51%
Ischemic heart disease 16%
Osteoporosis 16%
Diabetes 13%
Cancer 12%
Depression 11%
Atrial fibrillation 10%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, collagenase, clostridium histolyticum, 0.01 mg J0775 Office 22 3,330 $182,480
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 106 144 $106

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIAFLEX
  • Endo USA, Inc. $7,487
  • Endo Pharmaceuticals Inc. $2,610
$10,097 — 3,330

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

143 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record